Skip to content

Survey study, 2025

What causes premenstrual syndrome and premenstrual dysphoric disorder, and how common are they?

This review article explains the known biological, genetic and lifestyle factors behind premenstrual disorders rather than testing a treatment; it reports that any premenstrual disorder may affect up to 87% of women.

Early or limited evidence Women of reproductive age worldwide (literature review)

What they did

This is a narrative overview, not a trial. It summarises existing research on the types of premenstrual disorders and the biological mechanisms, genes and health conditions linked to them.

What they found

The prevalence of any premenstrual disorder is reported as up to 87% of women. Four variants of premenstrual disorders are described, including premenstrual exacerbation of other conditions. Fluctuations in hormones like estradiol, progesterone and testosterone, along with brain chemicals serotonin and GABA, are linked to symptoms. Several genes (SERT, COMT, MAOA, BDNF, ESR1, ESR2) have been studied in PMS. PMS is almost twice as common in women who are overweight or obese compared with normal-weight women, and women with metabolic syndrome and PMS tend to have poorer sleep and more depression and anxiety.

What it means for you

PMS and PMDD are common and involve a mix of hormones, genetics, and conditions like obesity and metabolic syndrome, so treatment may need to go beyond medication to include lifestyle changes and psychological support. As a review of existing studies, it does not provide new trial data and some findings, such as the obesity-related gene link, are described as controversial.

up to 87%

Prevalence of any premenstrual disorder

~2x higher

PMS rate in overweight/obese women

About the study

Original title
Current issues of the premenstrual disorders development
Authors
Iryna Oleksandrivna Kostitska, Nadiia Zherdova, А. Ya. Pavliak et al.
Journal
Reproductive health of woman
Year
2025
Study design
Survey study
What was tested
None tested; this is a review of mechanisms and risk factors
Open access
Yes
Original abstract

Premenstrual disorders remain one of the most prevalent pathologies in women all over the world. The core disorders – premenstrual syndrome (PMS) and premenstrual dysphoric disorder – predominate in women of reproductive age. Also, there are four variants of premenstrual disorders – premenstrual exacerbation, premenstrual disorders due to nonovulatory ovarian activity, progestogen-induced premenstrual disorders, premenstrual disorders with absent menstruation. Recently, the prevalence of any premenstrual disorder is up to 87% in female population.In this article some mechanisms that are involved in the pathogenesis of PMS are presented. The fluctuations of different hormones (namely, estradiol, progesterone, testosterone, etc.) and not normal response of the central nervous system to such variations can lead to psychological changes. Serotonin, serotonin transporter, gamma amonibutyric acid are involved in the mechanisms of mood disorders. Genetic factor is studied in different woman’s reproductive diseases. Gene polymorphism of SERT, COMT, MAOA, BDNF, ESR1 and ESR2 genes were studied most often in PMS development. One of the subtypes of premenstrual disorders is premenstrual exacerbation, when clinical manifestations of underlying diseases are expressed more before menstruation. Special attention is paid to the association of metabolic syndrome, overweight, obesity with premenstrual syndrome. There is a negative impact of these diseases of the regulation of menstrual cycle processes – early menarche onset, abnormal uterine bleeding (irregular periods, heavy menstrual bleeding or amenorrhea), hyperandrogenism, low concentration of sex steroid-binding globulin. It was found that the frequency of PMS in overweight and obese women is almost twice higher than in normal weight women. Women with metabolic syndrome who suffer from PMS have poor sleep quality, they are more depressive and anxiety. The most common association of gene between obesity, diabetes mellitus and PMS is related to angiotensin converting enzyme gene and its I/D polymorphism, however, the results of such relationship are controversial. It is very important the for different medical professionals to understand the manifestations of premenstrual disorders and prescribe to the patients not only medicament treatment, but also perform for them psychological support and give recommendations about lifestyle changes.

Reproduced under CC-BY.

Topics